144 related articles for article (PubMed ID: 31981688)
1. Differences in biological activities between recombinant human paraoxonase 1 (rhPON1) subtype isozemys R/Q as antidotes against organophosphorus poisonings.
Cui Y; Zhao M; Han L
Toxicol Lett; 2020 Jun; 325():51-61. PubMed ID: 31981688
[TBL] [Abstract][Full Text] [Related]
2. Effect of paraoxonase 1 192 Q/R polymorphism on paraoxonase and acetylcholinesterase enzyme activities in a Turkish population exposed to organophosphate.
Sunay SZ; Kayaaltı Z; Bayrak T; Söylemezoğlu T
Toxicol Ind Health; 2015 Dec; 31(12):1061-8. PubMed ID: 23625910
[TBL] [Abstract][Full Text] [Related]
3. Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning.
Stevens RC; Suzuki SM; Cole TB; Park SS; Richter RJ; Furlong CE
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12780-4. PubMed ID: 18711144
[TBL] [Abstract][Full Text] [Related]
4. Dual-Modal Nanoscavenger for Detoxification of Organophosphorus Compounds.
Zou S; Wang B; Wang Q; Liu G; Song J; Zhang F; Li J; Wang F; He Q; Zhu Y; Zhang L
ACS Appl Mater Interfaces; 2022 Sep; 14(37):42454-42467. PubMed ID: 36089739
[TBL] [Abstract][Full Text] [Related]
5. Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds.
Furlong CE
J Biochem Mol Toxicol; 2007; 21(4):197-205. PubMed ID: 17936934
[TBL] [Abstract][Full Text] [Related]
6. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds.
Li WF; Costa LG; Richter RJ; Hagen T; Shih DM; Tward A; Lusis AJ; Furlong CE
Pharmacogenetics; 2000 Dec; 10(9):767-79. PubMed ID: 11191881
[TBL] [Abstract][Full Text] [Related]
7. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of organophosphate toxicity and detoxication with emphasis on studies in Croatia.
Reiner E; Radić Z; Simeon-Rudolf V
Arh Hig Rada Toksikol; 2007 Sep; 58(3):329-38. PubMed ID: 17913688
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
[TBL] [Abstract][Full Text] [Related]
10. Progress in the development of enzyme-based nerve agent bioscavengers.
Nachon F; Brazzolotto X; Trovaslet M; Masson P
Chem Biol Interact; 2013 Dec; 206(3):536-44. PubMed ID: 23811386
[TBL] [Abstract][Full Text] [Related]
11. SAR study to find optimal cholinesterase reactivator against organophosphorous nerve agents and pesticides.
Gorecki L; Korabecny J; Musilek K; Malinak D; Nepovimova E; Dolezal R; Jun D; Soukup O; Kuca K
Arch Toxicol; 2016 Dec; 90(12):2831-2859. PubMed ID: 27582056
[TBL] [Abstract][Full Text] [Related]
12. Human paraoxonase double mutants hydrolyze V and G class organophosphorus nerve agents.
Kirby SD; Norris JR; Richard Smith J; Bahnson BJ; Cerasoli DM
Chem Biol Interact; 2013 Mar; 203(1):181-5. PubMed ID: 23159884
[TBL] [Abstract][Full Text] [Related]
13. Quaternary and tertiary aldoxime antidotes for organophosphate exposure in a zebrafish model system.
Schmidt HR; Radić Z; Taylor P; Fradinger EA
Toxicol Appl Pharmacol; 2015 Apr; 284(2):197-203. PubMed ID: 25701203
[TBL] [Abstract][Full Text] [Related]
14. In vivo evaluation of cholinesterase activity, oxidative stress markers, cyto- and genotoxicity of K048 oxime–a promising antidote against organophosphate poisoning.
Zunec S; Kopjar N; Zeljezić D; Kuca K; Musilek K; Lucić Vrdoljak A
Basic Clin Pharmacol Toxicol; 2014 Apr; 114(4):344-51. PubMed ID: 24741714
[TBL] [Abstract][Full Text] [Related]
15. Refolded Recombinant Human Paraoxonase 1 Variant Exhibits Prophylactic Activity Against Organophosphate Poisoning.
Bajaj P; Tripathy RK; Aggarwal G; Datusalia AK; Sharma SS; Pande AH
Appl Biochem Biotechnol; 2016 Sep; 180(1):165-76. PubMed ID: 27131877
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic potential of memantine against soman poisoning in rats.
Stojiljković MP; Škrbić R; Jokanović M; Bokonjić D; Kilibarda V; Vulović M
Toxicology; 2019 Mar; 416():62-74. PubMed ID: 30682440
[TBL] [Abstract][Full Text] [Related]
17. Toxicity and median effective doses of oxime therapies against percutaneous organophosphorus pesticide and nerve agent challenges in the Hartley guinea pig.
Snider TH; Babin MC; Jett DA; Platoff GE; Yeung DT
J Toxicol Sci; 2016; 41(4):511-21. PubMed ID: 27432237
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.
Worek F; Seeger T; Goldsmith M; Ashani Y; Leader H; Sussman JS; Tawfik D; Thiermann H; Wille T
Arch Toxicol; 2014 Jun; 88(6):1257-66. PubMed ID: 24477626
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of human paraoxonase 1 (PON1) by organophosphate pesticides in HepG2 cells.
Medina-Díaz IM; Ponce-Ruiz N; Ramírez-Chávez B; Rojas-García AE; Barrón-Vivanco BS; Elizondo G; Bernal-Hernández YY
Environ Toxicol; 2017 Feb; 32(2):490-500. PubMed ID: 26948828
[TBL] [Abstract][Full Text] [Related]
20. Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning.
Rochu D; Chabrière E; Masson P
Toxicology; 2007 Apr; 233(1-3):47-59. PubMed ID: 17007987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
